Published 11/07/2009 by News-Medical.Net
Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus
Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs)...
Share this
What others report on the same story